The transition from the Biden administration to the Trump administration has brought significant changes to the landscape of American health care policy. President Donald Trump's early actions have been focused on reversing key Biden-era programs aimed at lowering drug costs and expanding public
President Donald Trump's recent executive orders (EOs) have introduced significant restrictions on diversity, equity, and inclusion (DEI) programs across federal departments, with substantial implications for the healthcare industry. These orders prohibit DEI and DEIA (diversity, equity, inclusion,
Understanding the regulations for charging and delivering services to Medicaid patients is crucial for audiologists and hearing instrument specialists. With over 21% of the U.S. population enrolled in Medicaid, including more than 39% of children and youth under 19, healthcare providers must be
President Donald Trump began his second term with a series of executive actions aimed at undoing key policies implemented by the Biden administration, significantly impacting healthcare, immigration enforcement, the federal workforce, and domestic policies. These sweeping changes are poised to
The article explores the potential ramifications of the Trump administration's policies on the home-based care sector, underlined with historical precedents, potential outcomes, and advocacy challenges. The topic delves into how Trump's administration, known for its cost-cutting measures, could
The recent announcement by the FDA concerning the potential high-risk issue with Fresenius Kabi’s Ivenix large-volume infusion pumps (LVP) has raised important questions regarding the adequacy of safety measures in medical device usage. The initial alert followed a company communication from
